Skip to main content
. 2017 Sep 8;12(9):e0184178. doi: 10.1371/journal.pone.0184178

Table 2. Seroconversion patient number from (I) patients receiving only ustekinumab(II) patients receiving ustekinumab along with other treatment.

Patients receiving only ustekinumab (number = 117) Patients receiving ustekinumab along with other treatment as well (number = 17) p value
Seroconversion patient number 7 1 1